Sorbent Therapeutics Secures $18,056,217 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=728fd2af-607f-4714-9ce2-fe49b1851fc1&Preview=1
Date
8/8/2012
Company Name
Sorbent Therapeutics
Mailing Address
710 Lakeway Drive Sunnyvale, CA 94085
Company Description
Sorbent Therapeutics is a biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as End Stage Renal Disease (ESRD), Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), and Hypertension.
Website
http://www.sorbentrx.com
Transaction Type
Venture Equity
Transaction Amount
$18,056,217
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed